Abvc Biopharma (ABVC) Notes Payables (2010 - 2026)
Abvc Biopharma (ABVC) posted Notes Payables of $59,462 for Q2 2026, down 93.2% from $871,951 a year earlier and down 33.0% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Notes Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma's Notes Payables came in at $755,512, down 10.1% from FY2024.
- Annual Notes Payables has declined for three consecutive years, with a five-year compound annual growth rate of -14.2% (FY2020 to FY2025).
- In prior years, Abvc Biopharma's Notes Payables was $840,252 in FY2024 (-6.6%), $899,250 in FY2023 (-52.5%), $1.89 million in FY2022 (+15.5%) and $1.64 million in FY2021 (+0.7%).
- The Q2 2026 figure stands as the lowest quarterly Notes Payables since Q4 2015.
- On a year-over-year basis, Notes Payables has declined in each of the last seven quarters, with an average decline of 27.4% over the last eight quarters.
- The strongest year-over-year quarter for Notes Payables in the past five years was Q4 2022, with growth of 15.5%; the weakest was Q2 2026, with a decline of 93.2%.
- According to Business Quant data, Notes Payables for the three prior quarters was $88,737 (Q1 2026), $755,512 (Q4 2025) and $809,103 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59,462.00 |
| Mar 31, 2026 | 88,737.00 |
| Dec 31, 2025 | 755,512.00 |
| Sep 30, 2025 | 809,103.00 |
| Jun 30, 2025 | 871,951.00 |
| Mar 31, 2025 | 801,407.00 |
| Dec 31, 2024 | 840,252.00 |
| Sep 30, 2024 | 896,250.00 |
| Jun 30, 2024 | 956,880.00 |
| Mar 31, 2024 | 860,750.00 |
| Dec 31, 2023 | 899,250.00 |
| Sep 30, 2023 | 852,500.00 |
| Jun 30, 2023 | 882,750.00 |
| Mar 31, 2023 | 902,000.00 |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.64 Mn |
API Access
Abvc Biopharma Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();